Actinium Pharmaceuticals: Oversold Despite No Bad News (NYSE:ATNM)

Date:


Man backpacker hiking on footpath on scenic Runde island with ocean view in Norway

Anastasiia Shavshyna/E+ via Getty Images

Topline Summary and Update

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) is a biotech company focused on developed radiolabeled biologics to help treat patients with different forms of blood cancer. They have been on a straight-lined path



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Most meteorites come from just three sources

A pair of papers published today in Nature...

Tsuchinshan-ATLAS’ anti-tail | Astronomy Magazine

Tsuchinshan-ATLAS’ anti-tail | Astronomy Magazine ...

The Sun has reached solar maximum, NASA and NOAA scientists say

Back to Article List Aurora watchers and sun gazers,...

Polaris Dawn crew talks mission highlights, next steps

Polaris Dawn crewmembers (from left) Anna Menon, Sarah...